Correlation Between Stratasys and CanSino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stratasys and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stratasys and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stratasys and CanSino Biologics, you can compare the effects of market volatilities on Stratasys and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stratasys with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stratasys and CanSino Biologics.

Diversification Opportunities for Stratasys and CanSino Biologics

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Stratasys and CanSino is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Stratasys and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Stratasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stratasys are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Stratasys i.e., Stratasys and CanSino Biologics go up and down completely randomly.

Pair Corralation between Stratasys and CanSino Biologics

Given the investment horizon of 90 days Stratasys is expected to generate 0.8 times more return on investment than CanSino Biologics. However, Stratasys is 1.25 times less risky than CanSino Biologics. It trades about 0.01 of its potential returns per unit of risk. CanSino Biologics is currently generating about -0.02 per unit of risk. If you would invest  1,392  in Stratasys on November 7, 2024 and sell it today you would lose (147.00) from holding Stratasys or give up 10.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Stratasys  vs.  CanSino Biologics

 Performance 
       Timeline  
Stratasys 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Stratasys are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Stratasys unveiled solid returns over the last few months and may actually be approaching a breakup point.
CanSino Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CanSino Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, CanSino Biologics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Stratasys and CanSino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stratasys and CanSino Biologics

The main advantage of trading using opposite Stratasys and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stratasys position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.
The idea behind Stratasys and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world